Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,532 | -2,813 | -3,163 | -1,899 | -7,537 |
| Depreciation Amortization | 233 | 176 | 120 | 61 | 238 |
| Accounts receivable | 657 | 899 | 967 | 1,078 | -982 |
| Other Working Capital | -664 | -351 | 1,251 | 986 | -2,211 |
| Other Operating Activity | -5,303 | -3,556 | -1,823 | -1,063 | 3,632 |
| Operating Cash Flow | $-7,609 | $-5,645 | $-2,648 | $-837 | $-6,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -40 | -39 | -22 | -7 |
| Investing Cash Flow | $-40 | $-40 | $-39 | $-22 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,750 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 13,293 |
| Other Financing Activity | 5,826 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,076 | $N/A | $N/A | $N/A | $13,293 |
| Beginning Cash Position | 7,033 | 7,033 | 7,033 | 7,033 | 607 |
| End Cash Position | 2,460 | 1,348 | 4,346 | 6,174 | 7,033 |
| Net Cash Flow | $-4,573 | $-5,685 | $-2,687 | $-859 | $6,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,609 | -5,645 | -2,648 | -837 | -6,860 |
| Capital Expenditure | -40 | -40 | -39 | -22 | -7 |
| Free Cash Flow | -7,649 | -5,685 | -2,687 | -859 | -6,867 |